TP53 and pancreatic adenocarcinoma: TP53 mutations are present in various human cancers (pancreatic adenocarcinoma, liver hepatocellular carcinoma, chromophobe renal cell carcinoma, acute myeloid leukemia, thymoma, etc.)and represent potential prognostic markers (37).